Adar1 Capital Management, LLC Xenon Pharmaceuticals Inc. Transaction History
Adar1 Capital Management, LLC
- $500 Billion
- Q4 2024
A detailed history of Adar1 Capital Management, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 50,547 shares of XENE stock, worth $1.77 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
50,547
Previous 27,903
81.15%
Holding current value
$1.77 Million
Previous $1.1 Billion
80.37%
% of portfolio
0.4%
Previous 0.18%
Shares
3 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
66.7MCall Options Held
109KPut Options Held
2.1K-
Avoro Capital Advisors LLC New York, NY5.67MShares$199 Million3.24% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.52MShares$159 Million1.73% of portfolio
-
Braidwell LP Stamford, CT2.91MShares$102 Million6.4% of portfolio
-
Janus Henderson Group PLC London, X02.87MShares$101 Million0.06% of portfolio
-
Commodore Capital LP New York, NY2.74MShares$96.2 Million10.76% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.19B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...